Clinical and economic aspects of chronic cerebral ischemia treatment
Open Access
- 17 January 2025
- journal article
- Published by Publishing House OKI in Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice
- No. 4,p. 46-54
Abstract
Клинико-экономические аспекты лечения хронической ишемии головного мозгаKeywords
This publication has 22 references indexed in Scilit:
- Cognitive impairment and tactics of using the drug Cerebrolysin. Resolution of the International Council of Experts (May 12, 2023)S.S. Korsakov Journal of Neurology and Psychiatry, 2023
- Resolution of the Council of Experts on the topic “New treatment options for patients with chronic cerebral ischemia”, March 31, 2023Neurology, Neuropsychiatry, Psychosomatics, 2023
- Ampakines — a promising approach to neuroprotectionS.S. Korsakov Journal of Neurology and Psychiatry, 2022
- Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO)S.S. Korsakov Journal of Neurology and Psychiatry, 2021
- Efficacy and safety of treatment with ampasse: the results of a randomized, double-blind, placebo-controlled trial in patients with chronic cerebrovascular disordersS.S. Korsakov Journal of Neurology and Psychiatry, 2021
- Efficacy and safety of ethylmethylhydroxypyridine succinate in patients with chronic cerebral ischemiaS.S. Korsakov Journal of Neurology and Psychiatry, 2020
- Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy)Neurology, Neuropsychiatry, Psychosomatics, 2019
- Pharmacoeconomic analysis of the neuroprotective medicines in the treatment of ischemic strokeS.S. Korsakov Journal of Neurology and Psychiatry, 2019
- Oxidative stress and inflammation as links in a chain in patients with chronic cerebrovascular diseasesS.S. Korsakov Journal of Neurology and Psychiatry, 2019
- A randomized, double-blind, placebo-controlled study of the efficacy and safety of ampasse in the treatment of chronic cerebral ischemiaS.S. Korsakov Journal of Neurology and Psychiatry, 2019